Hyperorality is a distinctive feature of the behavioral variant of frontotemporal dementia (bvFTD), but little is known about its significance in early-stage disease. This study examined the cognitive and psychiatric symptom profiles associated with hyperorality, using data from subjects with early-stage bvFTD enrolled in Alzheimer’s Disease Research Centers. We found that hyperorality was not associated with cognitive performance, but was associated with psychosis, elation, and disinhibition. Hyperorality may share neurobiology with a subset of early psychiatric symptoms, a finding which could help identify targets for future treatment.
PiguetO, HornbergerM, ShelleyBP, KippsCM, HodgesJR (2009) Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology72, 732–737.
3.
MendezMF, LichtEA, ShapiraJS (2008) Changes in dietary or eating behavior in frontotemporal dementia versus Alzheimer’s disease. Am J Alzheimers Dis Other Demen23, 280–285.
4.
AhmedRM, IrishM, KamJ, van KeizerswaardJ, BartleyL, SamarasK, HodgesJR, PiguetO (2014) Quantifying the eating abnormalities in frontotemporal dementia. JAMA Neurol71, 1540–1546.
5.
OssenkoppeleR, PijnenburgYA, PerryDC, Cohn-SheehyBI, ScheltensNM, VogelJW, KramerJH, van der VliesAE, La JoieR, RosenHJ, van der FlierWM, GrinbergLT, RozemullerAJ, HuangEJ, van BerckelBN, MillerBL, BarkhofF, JagustWJ, ScheltensP, SeeleyWW, RabinoviciGD (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: Clinical, neuroimaging and pathological features. Brain138, 2732–2749.
6.
AhmedRM, IrishM, HenningE, DermodyN, BartleyL, KiernanMC, PiguetO, FarooqiS, HodgesJR (2016) Assessment of eating behavior disturbance and associated neural networks in frontotemporal dementia. JAMA Neurol73, 282–290.
7.
WhitwellJL, SampsonEL, LoyCT, WarrenJE, RossorMN, FoxNC, WarrenJD (2007) VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage35, 207–213.
8.
WoolleyJD, Gorno-TempiniML, SeeleyWW, RankinK, LeeSS, MatthewsBR, MillerBL (2007) Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology69, 1424–1433.
BeeklyDL, RamosEM, LeeWW, DeitrichWD, JackaME, WuJ, HubbardJL, KoepsellTD, MorrisJC, KukullWA, NIA Alzheimer’s Disease Centers (2007) The National Alzheimer’s Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Dis Assoc Disord21, 249–258.
11.
HughesCP, BergL, DanzigerWL, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
12.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
13.
MiyagawaT, BrushaberD, SyrjanenJ, KremersW, FieldsJ, ForsbergLK, HeuerHW, KnopmanD, KornakJ, BoxerA, RosenH, BoeveB, ConsortiumAL (2020) Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. Alzheimers Dement16, 79–90.
14.
SaariT, KoivistoA, HintsaT, HänninenT, HallikainenI (2022) Psychometric properties of the neuropsychiatric inventory: A review. J Alzheimers Dis86, 1485–1499.
15.
Da SilvaTBL, OrdonezTN, BregolaAG, BahiaVS, CecchiniMA, GuimarãesHC, GambogiLB, CaramelliP, BalthazarMLF, DamascenoBP, BruckiSMD, de SouzaLC, NitriniR, YassudaMS (2021) Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and Alzheimer’s disease: A 12-month follow-up study. Front Neurol12, 728108.
16.
FieldhouseJLP, GossinkFT, FeenstraTC, de BoerSCM, LemstraAW, PrinsND, BouwmanF, KoeneT, Rhodius-MeesterHFM, GillissenF, TeunissenCE, van der FlierWM, ScheltensP, DolsA, VijverbergEGB, PijnenburgYAL (2021) Clinical phenotypes of behavioral variant frontotemporal dementia by age at onset. J Alzheimers Dis82, 381–390.
FremontR, ManoochehriM, ArmstrongNM, MattayVS, ApudJA, TierneyMC, DevanandDP, GazesY, HabeckC, WassermannEM, GrafmanJ, HueyED (2020) Tolcapone treatment for cognitive and behavioral symptoms in behavioral variant frontotemporal dementia: A placebo-controlled crossover study. J Alzheimers Dis75, 1391–1403.
19.
ChenC, HsuFC, LiCW, HuangMC (2019) Structural, functional, and neurochemical neuroimaging of methamphetamine-associated psychosis: A systematic review. Psychiatry Res Neuroimaging292, 23–31.
20.
CummingsJL (1995) Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci769, 1–13.
21.
ShulmanKI (1997) Disinhibition syndromes, secondary mania and bipolar disorder in old age. J Affect Disord46, 175–182.
KesslerRM, HutsonPH, HermanBK, PotenzaMN (2016) The neurobiological basis of binge-eating disorder. Neurosci Biobehav Rev63, 223–238.
24.
LeoutsakosJM, ForresterSN, LyketsosCG, SmithGS (2015) Latent classes of neuropsychiatric symptoms in NACC controls and conversion to mild cognitive impairment or dementia. J Alzheimers Dis48, 483–493.
25.
ForresterSN, GalloJJ, SmithGS, LeoutsakosJM (2016) Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry24, 117–125.
26.
SellamiL, BocchettaM, MasellisM, CashDM, DickKM, van SwietenJ, BorroniB, GalimbertiD, TartagliaMC, RoweJB, GraffC, TagliaviniF, FrisoniG, FingerE, de MendonçaA, SorbiS, WarrenJD, RohrerJD, LaforceR; Genetic FTD Initiative, GENFI (2018) Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI Cohort. J Alzheimers Dis65, 147–163.
PiguetO, PetersénA, Yin Ka LamB, GaberyS, MurphyK, HodgesJR, HallidayGM (2011) Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol69, 312–319.
31.
IkedaM, ShigenobuK, FukuharaR, HokoishiK, MakiN, NebuA, KomoriK, TanabeH (2004) Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord17, 117–121.
32.
LebertF, StekkeW, HasenbroekxC, PasquierF (2004) Frontotemporal dementia: A randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord17, 355–359.
33.
SingamC, WalterfangM, MocellinR, EvansA, VelakoulisD (2013) Topiramate for abnormal eating behaviour in frontotemporal dementia. Behav Neurol27, 285–286.
34.
LeC, FingerE (2021) Pharmacotherapy for neuropsychiatric symptoms in frontotemporal dementia. CNS Drugs35, 1081–1096.
35.
SanchesC, LevyR, BenistyS, Volpe-GillotL, HabertMO, KasA, StröerS, PyatigorskayaN, KaglikA, BourbonA, DuboisB, MigliaccioR, Valero-CabréA, TeichmannM (2019) Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: A double blind, sham controlled, randomized clinical trial. Trials20, 632.
36.
SanchesC, StengelC, GodardJ, MertzJ, TeichmannM, MigliaccioR, Valero-CabréA (2020) Past, present, and future of non-invasive brain stimulation approaches to treat cognitive impairment in neurodegenerative diseases: Time for a comprehensive critical review. Front Aging Neurosci12, 578339.
37.
RegenoldWT, DengZD, LisanbySH (2022) Noninvasive neuromodulation of the prefrontal cortex in mental health disorders. Neuropsychopharmacology47, 361–372.
38.
DucharmeS, DolsA, LaforceR, DevenneyE, KumforF, van den StockJ, Dallaire-ThérouxC, SeelaarH, GossinkF, VijverbergE, HueyE, VandenbulckeM, MasellisM, TrieuC, OnyikeC, CaramelliP, de SouzaLC, SantilloA, WaldöML, Landin-RomeroR, PiguetO, KelsoW, EratneD, VelakoulisD, IkedaM, PerryD, PressmanP, BoeveB, VandenbergheR, MendezM, AzuarC, LevyR, Le BerI, BaezS, LernerA, EllajosyulaR, PasquierF, GalimbertiD, ScarpiniE, van SwietenJ, HornbergerM, RosenH, HodgesJ, Diehl-SchmidJ, PijnenburgY (2020) Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain143, 1632–1650.
39.
IkedaM, BrownJ, HollandAJ, FukuharaR, HodgesJR (2002) Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry73, 371–376.
